Regeneron Announces Investor Conference Presentations
Regeneron Pharmaceuticals (NASDAQ: REGN) has announced its participation in four major healthcare investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference (Sept 3), Wells Fargo Healthcare Conference (Sept 4), Morgan Stanley Global Healthcare Conference (Sept 8), and Bernstein Healthcare Forum (Sept 24).
All presentations will be accessible via webcast through Regeneron's investor relations website, with replays and transcripts available for at least 30 days after the events.
Regeneron Pharmaceuticals (NASDAQ: REGN) ha annunciato la sua partecipazione a quattro importanti conferenze per investitori nel settore sanitario previste per settembre 2025. L'azienda presenterà al Cantor Global Healthcare Conference (3 settembre), al Wells Fargo Healthcare Conference (4 settembre), al Morgan Stanley Global Healthcare Conference (8 settembre) e al Bernstein Healthcare Forum (24 settembre).
Tutte le presentazioni saranno disponibili in webcast tramite il sito web delle relazioni con gli investitori di Regeneron, con repliche e trascrizioni accessibili per almeno 30 giorni dopo gli eventi.
Regeneron Pharmaceuticals (NASDAQ: REGN) ha anunciado su participación en cuatro importantes conferencias para inversores del sector salud en septiembre de 2025. La compañía presentará en el Cantor Global Healthcare Conference (3 de septiembre), el Wells Fargo Healthcare Conference (4 de septiembre), el Morgan Stanley Global Healthcare Conference (8 de septiembre) y el Bernstein Healthcare Forum (24 de septiembre).
Todas las presentaciones estarán disponibles vía webcast a través del sitio web de relaciones con inversores de Regeneron, con repeticiones y transcripciones accesibles durante al menos 30 días después de los eventos.
Regeneron Pharmaceuticals (NASDAQ: REGN)는 2025년 9월에 열리는 네 개의 주요 헬스케어 투자자 컨퍼런스에 참여할 것이라고 발표했습니다. 회사는 Cantor Global Healthcare Conference(9월 3일), Wells Fargo Healthcare Conference(9월 4일), Morgan Stanley Global Healthcare Conference(9월 8일), 그리고 Bernstein Healthcare Forum(9월 24일)에서 발표할 예정입니다.
모든 발표는 Regeneron 투자자 관계 웹사이트를 통해 웹캐스트로 제공되며, 행사 후 최소 30일간 재생 및 녹취록을 확인할 수 있습니다.
Regeneron Pharmaceuticals (NASDAQ : REGN) a annoncé sa participation à quatre grandes conférences pour investisseurs dans le secteur de la santé en septembre 2025. La société présentera lors du Cantor Global Healthcare Conference (3 septembre), du Wells Fargo Healthcare Conference (4 septembre), du Morgan Stanley Global Healthcare Conference (8 septembre) et du Bernstein Healthcare Forum (24 septembre).
Toutes les présentations seront accessibles en webcast via le site des relations investisseurs de Regeneron, avec des rediffusions et des transcriptions disponibles pendant au moins 30 jours après les événements.
Regeneron Pharmaceuticals (NASDAQ: REGN) hat seine Teilnahme an vier bedeutenden Healthcare-Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird auf der Cantor Global Healthcare Conference (3. September), der Wells Fargo Healthcare Conference (4. September), der Morgan Stanley Global Healthcare Conference (8. September) und dem Bernstein Healthcare Forum (24. September) präsentieren.
Alle Präsentationen werden über Webcast auf der Investor-Relations-Website von Regeneron zugänglich sein, mit Wiederholungen und Transkripten, die mindestens 30 Tage nach den Veranstaltungen verfügbar sind.
- None.
- None.
TARRYTOWN, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:
- Cantor Global Healthcare Conference 2025 at 1:35 p.m. ET on Wednesday, September 3, 2025
- 2025 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Thursday, September 4, 2025
- Morgan Stanley 23rd Annual Global Healthcare Conference at 11:30 a.m. ET on Monday, September 8, 2025
- Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum at 10:30 a.m. ET on Wednesday, September 24, 2025
The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days.
About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.
Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.
Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com
FAQ
When is Regeneron (REGN) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access Regeneron's conference presentations in September 2025?
Which investor conferences will Regeneron (REGN) attend in September 2025?
How long will Regeneron's conference presentation replays be available?
